ACRO Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	86.07	191.75	544.16	281.85	32.26	45.66
Short-Term Investments	367.2	307.2	35.07	35.01	30.71	71.12
Cash & Short-Term Investments	453.27	498.95	579.23	316.85	62.97	116.77
Cash Growth	-14.79%	-13.86%	82.81%	403.18%	-46.08%	110.56%
Accounts Receivable	3.87	7.87	4.83	10.3	6.23	4.71
Other Receivables	0.98	2.15	3.39	0.17	0.08	0.19
Receivables	4.85	10.02	8.23	10.47	6.31	4.9
Inventory	11.5	10.7	9.51	12.51	14.63	13.46
Prepaid Expenses	11.78	9.71	10.85	12.57	18.27	17.26
Total Current Assets	481.39	529.38	607.81	352.4	102.17	152.39
Property, Plant & Equipment	58.59	56.23	45.81	21.89	26.39	32.45
Long-Term Investments	43.24	46.06	47.39	13.74	13.44	11.43
Other Intangible Assets	6.42	6.33	8.47	8.01	7.97	4.02
Other Long-Term Assets	17.89	17.32	7.25	2.49	1.31	3.14
Total Assets	607.52	655.33	716.74	398.53	151.29	203.43
Accounts Payable	0.69	0.75	0.95	1.21	0.11	2.42
Accrued Expenses	9.8	9.85	8.09	-	-	-
Current Portion of Leases	3.78	5.26	5.25	3.67	3.39	3.39
Current Unearned Revenue	0.67	2.5	0.19	0.08	0.31	3.17
Other Current Liabilities	1.73	0.1	0.33	7.72	7.53	4.9
Total Current Liabilities	16.66	18.46	14.81	12.68	11.34	13.88
Long-Term Leases	9.42	10.59	15.85	7.25	9.93	11.14
Total Liabilities	26.08	29.05	30.66	19.92	21.27	25.02
Common Stock	612.18	612.18	612.18	512.18	354.33	354.33
Additional Paid-In Capital	253.2	251.39	250	160.3	9.56	122.66
Retained Earnings	-280.8	-236.71	-174.62	-293.5	-232.62	-296.34
Comprehensive Income & Other	-3.14	-0.59	-1.48	-0.37	-1.25	-2.25
Shareholders' Equity	581.44	626.28	686.08	378.61	130.02	178.41
Total Liabilities & Equity	607.52	655.33	716.74	398.53	151.29	203.43
Total Debt	13.2	15.85	21.1	10.92	13.32	14.53
Net Cash (Debt)	440.07	483.1	558.13	305.93	49.65	102.25
Net Cash Growth	-14.29%	-13.44%	82.43%	516.20%	-51.44%	159.22%
Net Cash Per Share	7.19	7.89	10.59	6.48	1.40	3.37
Filing Date Shares Outstanding	61.22	61.22	54.18	47.2	35.51	30.31
Total Common Shares Outstanding	61.22	61.22	54.18	47.2	35.51	30.31
Working Capital	464.73	510.92	593	339.72	90.83	138.52
Book Value Per Share	9.50	10.23	12.66	8.02	3.66	5.89
Tangible Book Value	575.02	619.94	677.61	370.6	122.05	174.39
Tangible Book Value Per Share	9.39	10.13	12.51	7.85	3.44	5.75
Machinery	69.55	59.3	45.42	-	-	-
Construction In Progress	0.63	0.63	16.51	-	-	-
Leasehold Improvements	58.92	59.04	36.36	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.